바로가기메뉴

본문 바로가기 주메뉴 바로가기

Endobronchial Metastases from Extrathoracic Malignancies: Recent 10 Years' Experience in a Single University Hospital

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2013, v.74 no.4, pp.169-176
(CHA University College of Medicine)
Daniel Min (CHA University College of Medicine)
Sang-Hee Song (CHA University College of Medicine)



  • Downloaded
  • Viewed

Abstract

Background: Although the lung is a common site of metastasis, endobronchial metastases (EBM) from extrathoracic malignancies are rare. Previous studies were retrospective reviews of the cases from each single institute, and the last one was performed between 1992 and 2002. We evaluated the characteristics of patients with EBM who had been diagnosed in recent 10 years in our hospital. Methods: We retrospectively reviewed 1,275 patients who had undergone diagnostic bronchoscopic procedures between 2001 and 2011. An EBM was defined as bronchoscopically notable lesion, which was histopathologically identical to the primary tumor. Results: A total of 18 cases of EBM were identified. The mean age was 53 years, and 12 cases of the 18 patients were female. The most common primary malignancies were colorectal cancer and breast cancer (4 cases each), followed by cervix cancer (3 cases) and renal cell carcinoma (2 cases). Cough was the most common symptom. The most common radiologic finding was atelectasis, which was identified in 27.7% of the cases. The median interval from the diagnosis of primary malignancy to the diagnosis of EBM was 14 months (range, 0–112 months). The median survival time from the diagnosis of EBM was 10 months (range, 1–39 months). Conclusion: EBM from extrathoracic malignancies were rare. Colorectal cancer and breast cancer were common as primary malignancies. Fiberoptic bronchoscopy should be performed in all patients, who are suspected of having EBM. If atypical clinical and pathological features are present, appropriate diagnostic studies should be undertaken.

keywords
Bronchi, Neoplasm Metastasis, Neoplasms

Reference

1.

Rosenblatt MB, Lisa JR, Trinidad S. Pitfalls in the clinical histologic diagnosis of bronchogenic carcinoma. Dis Chest 1966;49:396-404.

2.

Braman SS, Whitcomb ME. Endobronchial metastasis. Arch Intern Med 1975;135:543-7.

3.

Fitzgerald RH Jr. Endobronchial metastases. South Med J 1977;70:440-1.

4.

Baumgartner WA, Mark JB. Metastatic malignancies from distant sites to the tracheobronchial tree. J Thorac Cardiovasc Surg 1980;79:499-503.

5.

Shepherd MP. Endobronchial metastatic disease. Thorax 1982;37:362-5.

6.

Bourke SJ, Henderson AF, Stevenson RD, Banham SW. Endobronchial metastases simulating primary carcinoma of the lung. Respir Med 1989;83:151-2.

7.

Lee HL, Kwak SM, Chang JH, Kim SK, Kim SK, Lee WY, et al. Endobronchial metastasis of extrapulmonary malignancies. Korean J Intern Med 1992;43:806-13.

8.

Heitmiller RF, Marasco WJ, Hruban RH, Marsh BR. Endobronchial metastasis. J Thorac Cardiovasc Surg 1993;106:537-42.

9.

Salud A, Porcel JM, Rovirosa A, Bellmunt J. Endobronchial metastatic disease: analysis of 32 cases. J Surg Oncol 1996;62:249-52.

10.

Wang YH, Wong SL, Lai YF, Lin AS, Chang HW. Endobronchial metastatic disease. Changgeng Yi Xue Za Zhi 1999;22:240-5.

11.

Katsimbri PP, Bamias AT, Froudarakis ME, Peponis IA, Constantopoulos SH, Pavlidis NA. Endobronchial metastases secondary to solid tumors: report of eight cases and review of the literature. Lung Cancer 2000;28:163- 70.

12.

Kiryu T, Hoshi H, Matsui E, Iwata H, Kokubo M, Shimokawa K, et al. Endotracheal/endobronchial metastases: clinicopathologic study with special reference to developmental modes. Chest 2001;119:768-75.

13.

Kim DH, Park MS, Chung JH, Cheong JH, Kim SK, Chang J, et al. Endobronchial metastasis of extrapulmonary malignancies. Tuberc Respir Dis 2002;53: 285-93.

14.

Akoglu S, Ucan ES, Celik G, Sener G, Sevinc C, Kilinc O, et al. Endobronchial metastases from extrathoracic malignancies. Clin Exp Metastasis 2005;22:587-91.

15.

Center MM, Jemal A, Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev 2009;18:1688-94.

16.

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61: 69-90.

17.

Statistics Korea [Internet]. Daejeon: Korean Statistical Information Service; c1999-2009 [cited 2012 Sep 12]. Available from: http://www.kosis.kr/abroad/abroad_ 01List.jsp.

18.

Sleeman JP, Thiele W. Tumor metastasis and the lymphatic vasculature. Int J Cancer 2009;125:2747-56.

19.

Sleeman JP, Cady B, Pantel K. The connectivity of lymphogenous and hematogenous tumor cell dissemination: biological insights and clinical implications. Clin Exp Metastasis 2012;29:737-46.

20.

Carlin BW, Harrell JH 2nd, Olson LK, Moser KM. Endobronchial metastases due to colorectal carcinoma. Chest 1989;96:1110-4.

21.

Pisch J, Villamena PC, Harvey JC, Rosenblatt E, Mishra S, Beattie EJ. High dose-rate endobronchial irradiation in malignant airway obstruction. Chest 1993;104:721-5.

22.

Quantrill SJ, Burt PA, Barber PV, Stout R. Treatment of endobronchial metastases with intraluminal radiotherapy. Respir Med 2000;94:369-72.

23.

Solomonov A, Rosenblatt E, Ben-Izhak O, Goralnik L, Yigla M. High-dose-rate endobronchial brachytherapy in endobronchial metastatic malignant chondroid syringoma. Respiration 2001;68:406-10.

Tuberculosis & Respiratory Diseases